On Monday, the FDA approved Truvada, the first medication intended to prevent HIV infections in people having sex with infected partners. In clinical trials where HIV-negative individuals had unprotected sex with multiple partners, including some with HIV, the pill reduced the risk of infection by 42 percent compared with a placebo. Another trial with heterosexual couples where one partner was infected found that Truvada, which is taken daily, reduced the risk by 75 percent. The FDA warned that the drug, which will cost patients about $450 a year, should be used in conjunction with other prevention methods.
THE WEEK'S AUDIOPHILE PODCASTS: LISTEN SMARTER
- Syrian women know how to defeat ISIS
- 10 things you need to know today: October 22, 2014
- The U.S. Marines are developing laser weapons. Here's why.
- 43 TV shows to watch in 2014
- How to be the most productive person in your office — and still get home by 5:30 p.m.
- 3 horrific inaccuracies in Homeland's depiction of Islamabad
- The one thing the New Atheists get right about religion
- Will Kobani be ISIS's Waterloo?
- How to make corn dogs
- 5 baffling foreign-language versions of the Fresh Prince of Bel-Air theme song
Subscribe to the Week